Recent developments in anti-inflammatory natural products

Medicinal Research Reviews

Volumn 29, Issue 5, 2009, Pages 767-820

  Gautam, Raju ^a   Jachak, Sanjay M ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Alkaloids; Anti inflammatory; Natural products; Polyphenolics; Terpenoids

Indexed keywords

ACETYLSALICYLIC ACID; ALKALOID; ANTIINFLAMMATORY AGENT; BAICALEIN; BERBERINE; BETULIC ACID; BOSWELLIC ACID; CELASTROL; CHRYSIN; CURCUMIN; CYCLOOXYGENASE 2 INHIBITOR; DEHYDROEVODIAMINE; DOCOSAHEXAENOIC ACID; EVODIAMINE; FLAVONOID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NATURAL PRODUCT; NIMESULIDE; OLEANOLIC ACID DERIVATIVE; QUINONE DERIVATIVE; RESVERATROL; RUTAECARPINE; SINOMENINE; STEROID; TERPENOID; TRIPTOLIDE; TRYPTANTHRIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; URSOLIC ACID DERIVATIVE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; CHRONIC PANCREATITIS; CLINICAL TRIAL; COLITIS; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG RECEPTOR BINDING; EAR DISEASE; EDEMA; ENZYME ACTIVATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IRRITANT DERMATITIS; LUPUS VULGARIS; NONHUMAN; OSTEOARTHRITIS; PAW EDEMA; PROTEIN EXPRESSION; PSORIASIS VULGARIS; REVIEW; RHEUMATOID ARTHRITIS; SKIN INFLAMMATION; STRUCTURE ACTIVITY RELATION; ULCERATIVE COLITIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL PRODUCTS; HUMANS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 69449105731     PISSN: 01986325     EISSN: None     Source Type: Journal    
DOI: 10.1002/med.20156     Document Type: Review

References (241)

1. Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Org 2003;81:646-656.
2. Smith RJ. Therapies for rheumatoid arthritis: Hope springs eternal. Drug Discov Today 2005;10:1598-1606. (Pubitemid 41817608)
3. Mantovani A, Pierotti MA. Cancer and inflammation: A complex relationship. Cancer Lett 2008;267:180-181.
4. Lawrence T. Inflammation and cancer: A failure of resolution? TRENDS Pharmacol Sci 2007;28:162-165.
5. Schimmer BP, Parker KL. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; Inhibitors of the synthesis and actions of adrenocortical hormones. In: Hardman JG, Limbird LE, Gilman AG, editors. Goodman and Gilman's The pharmacological basis of therapeutics. 10th Edition. USA: McGraw; 2001. pp 1649-1677.
6. Jachak SM. Cyclooxygenase inhibitory natural products: Current status. Curr Med Chem 2006;13:659-678.
7. Strand V, Kimberly R, Isaacs JD. Biologic therapies in rheumatology: Lessons learned future directions. Nature Rev Drug Discov 2007;6:75-92. (Pubitemid 46020288)
8. Tincani A, Andreoli L, Bazzani C, Bosiso D, Sozzani S. Inflammatory molecules: A target for the treatment of systemic autoimmune diseases. Autoimmun Rev 2007;7:1-7. (Pubitemid 47633384)
9. Simmons, DL. What makes a good anti-inflammatory drug target? Drug Discov Today 2006;11:210-219.
10. McCulloch CA, Downey GP, El-Gabalawy H. Signaling platforms that modulate the inflammatory response: New targets for drug development. Nature Rev Drug Discov 2006;5:864-876. (Pubitemid 44480540)
11. Schmitz ML, Bacher S. Novel molecular targets in the search for anti-inflammatory agents. Phytochemistry Rev 2005;4:19-25. (Pubitemid 41187756)
12. Hume DA, Fairlie DP. Therapeutic targets in inflammatory disease. Curr Med Chem 2005;12:2925-2929.
13. Roman-Blass JA, Jimenez SA. NF-κB as a therapeutic target in osteoarthritis and rheumatoid arthritis. Osteoarthritis Cartilage 2006;14:839-848. (Pubitemid 44138675)
14. Newman DJ, Cragg GM. Natural products as sources of new drugs over the last 25 years. J Nat Prod 2007;70:461-477.
15. Jachak SM, Saklani A. Challenges and opportunities in drug discovery from plants. Curr Sci 2007;92:1251-1257. (Pubitemid 46834050)
16. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 1971;231:232-235.
17. Schneider I, Bucar F. Lipoxygenase inhibitors from natural plant sources. Part 1: Medicinal plants with inhibitory activity on arachidonate 5-lipoxygenase and 5-lipoxygenase/cyclooxygenase. Phytother Res 2005;19:81-102.
18. Schneider I, Bucar F. Lipoxygenase inhibitors from natural plant sources. Part 2: Medicinal plants with inhibitory activity on arachidonate 12-lipoxygenase, 15-lipoxygenase and leukotriene antagonists. Phytother Res 2005;19:263-272.
19. Calixto JB, Otuki MF, Santos ARS. Anti-inflammatory compounds of plant origin. Part I. Action on arachidonic acid pathway, nitric oxide and nuclear factor-κB (NF-κB). Planta Med 2003;69:973-983.
20. Bremner P, Heinrich M. Natural products and their role as inhibitors of the pro-inflammatory transcription factor NF-κB. Phytochemistry Rev 2005;4:27-37. (Pubitemid 41199794)
21. Paul AT, Gohil VM, Bhutani KK. Modulating TNF-α signaling with natural products. Drug Discov Today 2006;11:725-732.
22. Calixto JB, Campos MM, Otuki MF, Santos ARS. Anti-inflammatory compounds of plant origin. Part II. Modulation of pro-inflammatory cytokines, chemokines and adhesion molecules. Planta Med 2004;70:93-103.
23. Rahman I, Biswas SK, Kirkham PA. Regulation of inflammation and redox signaling by dietary polyphenols. Biochem Pharmacol 2006;72:1439-1452. (Pubitemid 44666744)
24. Bucar F, Jachak SM, Noreen Y, Kartnig T, Perera P, Bohlin L, Schubert-Zsilavecz M. Amentoflavone from Biophytum sensitivum and its effect on COX-1/COX-2 catalysed prostaglandin biosynthesis. Planta Med 1998;64:373-374. (Pubitemid 28234280)
25. Selvam C, Jachak SM, Bhutani KK. Cyclooxygenase inhibitory flavonoids from the stem bark of Semecarpus anacardium Linn. Phytother Res 2004;18:582-584. (Pubitemid 39079158)
26. Selvam C, Jachak SM. A cyclooxygenase (COX) inhibitory biflavonoid from the seeds of Semecarpus anacardium. J Ethnopharmacol 2004;95:209-212. (Pubitemid 39422672)
27. Selvam C, Jachak SM, Oli RG, Thilagavathi R, Chakraborti AK, Bhutani KK. A new cyclooxygenase (COX) inhibitory pterocarpan from Indigofera aspalathoides: Structure elucidation and determination of binding orientations in the active sites of the enzyme by molecular docking. Tetrahedron Lett 2004;45:4311-4314. (Pubitemid 38610072)
28. Selvam C, Jachak SM, Thilagavathi R, Chakraborti AK. Design, synthesis, biological evaluation and molecular docking of curcumin analogues as antioxidant, cyclooxygenase inhibitory and anti-inflammatory agents. Bioorg Med Chem Lett 2005;15:1793-1797. (Pubitemid 40380734)
29. Jachak SM, Selvam C, Srivastava A, Ahuja V. Evaluation of anti-inflammatory activity and identification of bioactive compounds from Vitex negundo L., Cardiospermum helicacabum L. and Tridax procumbens L. Planta Med 2007;73:802-803.
30. Danz H, Stoyanova S, Wippich P, Brattstrom A, Hamburger M. Identification and isolation of the cyclooxygenase-2 inhibitory principle in Isatis tinctoria. Planta Med 2001;67:411-416. (Pubitemid 32652575)
31. Danz H, Baumann D, Hamburger M. Quantitative determination of the dual COX-2/5-LOX inhibitor tryptanthrin in Isatis tinctoria by ESI-LC-MS. Planta Med 2002;68:152-157. (Pubitemid 34169409)
32. Danz H, Stoyanova S, Thomet OAR, Simon HU, Dannhardt G, Ulbrich H, Hamburger M. Inhibitory activity of tryptanthrin on prostaglandin and leukotriene synthesis. Planta Med 2002;68:875-880. (Pubitemid 35239275)
33. Ishihara T, Kohno K, Ushio S, Iwaki K, Ikeda M, Kurimoto M. Tryptanthrin inhibits nitric oxide and prostaglandin E2 synthesis by murine macrophages. Eur J Pharmacol 2000;407:197-204. (Pubitemid 30767855)
34. Micallef MJ, Iwaki K, Ishihara T, Ushio S, Aga M, Kunikata T, Koya-Miyata S, Kimoto T, Ikeda M, Kurimoto M. The natural plant product tryptanthrin ameliorates dextran sodium sulfate-induced colitis in mice. Int Immunopharmacol 2002;2:565-578. (Pubitemid 34169751)
35. Heinemann C, Schliemann-Willers S, Oberthur C, Humburger M, Elsner P. Prevention of experimentally induced irritant contact dermatitis by extracts of Isatis tinctoria compared to pure tryptanthrin and its impact on UVB-induced erythema. Planta Med 2004;70:385-390. (Pubitemid 38716468)
36. Woo HG, Lee CH, Noh M-S, Lee JJ, Jung Y-S, Baik EJ, Moon C-H, Lee SH. Rutaecarpine, a quinazolinocarboline alkaloid, inhibits prostaglandin production in RAW264.7 macrophages. Planta Med 2001;67:505-509.
37. Choi YH, Shin EM, Kim YS, Cai XF, Lee JJ, Kim HP. Anti-inflammatory principles from the fruits of Evodia rutaecarpa and their cellular action mechanisms. Arch Pharm Res 2006;29:293-297.
38. Noh EJ, Ahn KS, Shin EM, Jung SH, Kim YS. Inhibition of lipopolysaccharide-induced iNOS and COX-2 expression by dehydroevodiamine through suppression of NF-κB activation in RAW 264.7 macrophages. Life Sci 2006;79:695-701. (Pubitemid 43927982)
39. Ko H-C, Wang Y-H, Liou K-T, Chen C-M, Chen C-H, Wang W-Y, Chang S, Hou Y-C, Chen K-T, Chen C-F, Shen Y-C. Anti-inflammatory effects and mechanisms of the ethanol extract of Evodia rutaecarpa and its bioactive components on neutrophils and microglial cells. Eur J Pharmacol 2007;555:211-217. (Pubitemid 46048800)
40. Moon TC, Murakami M, Kudo I, Son KH, Kim HP, Kang SS, Chang HW. A new class of COX-2 inhibitor, rutaecarpine from Evodia rutaecarpa. Inflamm Res 1999;48:621-625. (Pubitemid 30017099)
41. Shin Y-K, Bae E-A, Cai XF, Lee JJ, Kim D-H. In vitro and in vivo antiallergic effect of the fructus of Evodia rutaecarpa and its constituents. Biol Pharm Bull 2007;30:197-199.
42. Jeon TW, Jin CH, Lee SK, Jun IH, Kim GH, Lee DJ, Jeong HG, Lee K-B, Jahng Y, Jeong TC. Immunosuppressive effects of rutaecarpine in female BALB/c mice. Toxicol Lett 2006;164:155-166.
43. Adams M, Kunert O, Haslinger E, Bauer R. Inhibition of leukotriene biosynthesis by quinolone alkaloids from the fruits of Evodia rutaecarpa. Planta Med 2004;70:904-908. (Pubitemid 39457798)
44. Yarosh DB, Galvin JW, Nay SL, Pena AV, Canning MT, Brown DA. Anti-inflammatory activity in skin by biomimetic of Evodia rutaecarpa extract from traditional Chinese medicine. J Dermatol Sci 2006;42:13-21.
45. Wang Y, Fang Y, Huang W, Zhou X, Wang M, Zhong B, Peng D. Effect of sinomenine on cytokine expression of macrophages and synoviocytes in adjuvant arthritis rats. J Ethnopharmacol 2005;98:37-43. (Pubitemid 40349165)
46. Feng H, Yamaki K, Takano H, Inoue K, Yanagisawa R, Yoshino S. Effect of sinomenine on collagen-induced arthritis in mice. Autoimmunity 2007;40:532-539. (Pubitemid 351233175)
47. Cheng H, Xia B, Guo Q, Zhang L, Wang F, Jiang L, Wang Z, Zhang Y, Li C. Sinomenine attenuates 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice. Int Immunopharmacol 2007;7:604-611.
48. Chen Y, Yang C, Jin N, Xie Z, Fei L, Jia Z, Wu Y. Sinomenine promotes differentiation but impedes maturation and co-stimulatory molecule expression of human monocyte-derived dendritic cells. Int Immunopharmacol 2007;7:1102-1110. (Pubitemid 46900912)
49. Huang J, Lin Z, Luo M, Lu C, Kim MH, Yu B, Gu J. Sinomenine suppresses TNF-α-induced VCAM-1 expression in human umbilical vein endothelial cells. J Ethnopharmacol 2007;114: 180-185. (Pubitemid 47539818)
50. Zeng Y, Gu B, Ji X, Ding X, Song C, Wu F. Sinomenine, an antirheumatic alkaloid, ameliorates clinical signs of disease in the lewis rat model of acute experimental autoimmune encephalolmyelitis. Biol Pharm Bull 2007;30:1438-1444. (Pubitemid 47282190)
51. Zhao Y, Li J, Yu K, Liu Y, Chen X. Sinomenine inhibits maturation of monocyte-derived dendritic cells through blocking activation of NF-κB. Int Immunopharmacol 2007;7: 637-645. (Pubitemid 46453275)
52. Qian L, Xu Z, Zhang W, Wilson B, Hong J-S, Flood PM. Sinomenine, a natural dextrorotatory morphinan analogue, is anti-inflammatory and neuroprotective through inhibition of microglial NADPH oxidase. J Neuroinflamm 2007;4:23-37. (Pubitemid 350066535)
53. Tang Q, Luo J, Zhu Q, Li Y, Yin S. Synthesis and anti-inflammatory activities investigation of sinomenine derivatives on ring C. Nat Prod Res 2006;20:1015-1023. (Pubitemid 44566680)
54. Choi HS, Kim HS, Min KR, Kim Y, Lim HK, Chang YK, Chung MW. Anti-inflammatory effects of fangchinoline and tetrandrine. J Ethnopharmacol 2000;69:173-179.
55. Shen YC, Chou CJ, Chiou WF, Chen C. Anti-inflammatory effects of the partially purified extract of radix Stephaniae tetrandrae: comparative studies of its active principles tetrandrine and fangchinoline on human polymorphonuclear leukocyte functions. Mol Pharmacol 2001;60: 1083-1090. (Pubitemid 33027444)
56. Wu S-J, Ng L-T. Tetrandrine inhibits proinflammatory cytokines, iNOS and COX-2 expression in human monocytic cells. Biol Pharm Bull 2007;30:59-62.
57. Ho L-H, Juan T-Y, Chao P, Wu W-L, Chang D-M, Chang S-Y, Lai J-H. Plant alkaloid tetrandrine downregulates IκBα kinases-IκBα-NF- κB signaling pathway in human peripheral blood T cell. Br J Pharmacol 2004;143:919-927. (Pubitemid 39664851)
58. Fukuda K, Hibiya Y, Mutoh M, Koshiji M, Akao S, Fujiwara H. Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells. J Ethnopharmacol 1999;66:227-233. (Pubitemid 29307925)
59. Kuo C-L, Chi C-W, Liu T-Y. The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett 2003;203:127-137.
60. Choi BH, Ahn I-S, Kim Y-H, Park J-W, Lee S-Y, Hyun C-K, Do M-S. Berberine reduces the expression of adipogenic enzymes and inflammatory molecules of 3T3-L1 adipocyte. Exp Mol Med 2006;38:599-605.
61. Lee CH, Chen J-C, Hsiang C-Y, Wu S-L, Wu H-C, Ho T-Y. Berberine suppresses inflammatory agents-induced interleukin-1b and tumor necrosis factor-α productions via the inhibition of IκB degradation in human lung cells. Pharmacol Res 2007;56:193-201.
62. Kim KW, Ha K-T, Park C-S, Jin U-H, Chang HW, Lee I-S, Kim C-H. Polygonum cuspidatum, compared with baicalin and berberine, inhibits inducible nitric oxide synthase and cyclooxygenase-2 gene expressions in RAW 264.7 macrophages. Vascul Pharmacol 2007;47:99-107.
63. Kang BY, Chung SW, Cho D, Kim TS. Involvement of p38 mitogen-activated protein kinase in the induction of interleukin-12 p40 production in mouse macrophages by berberine, a benzodioxoloquinolozine alkaloid. Biochem Pharmacol 2002;63:1901-1910. (Pubitemid 34603455)
64. Hu J-P, Nishishita K, Sakai E, Yoshida H, Kato Y, Tsukuba T, Okamoto K. Berberine inhibits RANKL-induced osteoclast formation and survival through suppressing the NF-κB and Akt pathways. Eur J Pharmacol 2008;580:70-79.
65. Kupeli E, Kosar M, Yesilada E, Baser KHC, Baser C. A comparative study on the anti-inflammatory, antinociceptive and antipyretic effects of isoquinoline alkaloids from the roots of Turkish Berberis species. Life Sci 2002;72:645-657. (Pubitemid 35441232)
66. Lee DU, Kang YJ, Park MK, Lee YS, Seo HG, Kim TS, Kim CH, Chang KC. Effects of 13-alkyl-substituted berberine alkaloids on the expression of COX-II, TNF-α, iNOS, and IL-12 production in LPS-stimulated macrophages. Life Sci 2003;73:1401-1412.
67. Chiou WF, Peng CH, Chen CF, Chou CJ. Anti-inflammatory properties of piperlactam S: Modulation of complement 5a-induced chemotaxis and inflammatory cytokines production in macrophages. Planta Med 2003;69:9-14.
68. Chiou W-F, Shum AYC, Peng C-H, Chen C-F, Chou C-J. Piperlactam S suppresses macrophage migration by impeding F-actin polymerization and filopodia extension. Eur J Pharmacol 2003;458:217-225.
69. Yin W, Wang TS, Yin FZ, Cai BC. Analgesic and anti-inflammatory properties of brucine and brucine N-oxide extracted from seeds of Strychnos nux-vomica. J Ethnopharmacol 2003;88:205-214. (Pubitemid 37083448)
70. Lee BG, Kim HS, Zee OP, Lee KR, Lee HY, Han JW, Lee HW. Suppression of inducible nitric oxide synthase expression in RAW 264.7 macrophages by two β-carboline alkaloids extracted from Melia azedarach. Eur J Pharmacol 2000;406:301-309.
71. Ringbom T, Huss U, Stenholm A, Flock S, Skattebol L, Perera P, Bohlin L. COX-2 inhibitory effects of naturally occurring and modified fatty acids. J Nat Prod 2001;64:745-749. (Pubitemid 32565922)
72. Su B-N, Cuendet M, Farnsworth NR, Fong HHS, Pezzuto JM, Kinghorn AD. Activity-guided fractionation of the seeds of Ziziphus jujuba using a cyclooxygenase-2 inhibitor assay. Planta Med 2002;68:1125-1128. (Pubitemid 36140320)
73. Jang DS, Cuendet M, Su B-N, Totura S, Riswan S, Fong HHS, Pezzuto JM, Kinghorn AD. Constituents of the seeds of Hernandia ovigera with inhibitory activity against cyclooxygenase-2. Planta Med 2004;70:893-896. (Pubitemid 39457796)
74. Shrestha R, Kim S-C, Dyer JM, Dixon RA, Chapman KD. Plant fatty acid (ethanol) amide hydrolases. Biochim Biophys Acta Mol Cell Biol Lipids 2006;1761:324-334.
75. Marzo VD, Maccarrone M. FAAH and anandamide: is 2-AG really the odd one out? Trends Pharmacol Sci 2008;29:229-233.
76. Chapman KD. Occurrence, metabolism, and prospective functions of N-acylethanolamines in plants. Prog Lipid Res 2004;43:302-327.
77. Venables BJ, Waggoner CA, Chapman KD. N-acylethanolamines in seeds of selected legumes. Phytochemistry 2005;66:1913-1918.
78. Verme JL, Fu J, Astarita G, La Rana G, Russo R, Calignano A, Piomelli D. The nuclear receptor peroxisome proliferator-activated receptor-α mediates the anti-inflammatory actions of palmitoylethanolamide. Mol Pharmacol 2005;67:15-19. (Pubitemid 40069962)
79. Shen CC, Wang Y-H, Chang T-T, Lin L-C, Don M-J, Hou Y-C, Lio K-T, Chang S, Wang W-Y, Ko H-C, Shen Y-C. Anti-inflammatory ergostanes from the basidiomata of Antrodia salmonea. Planta Med 2007;73:1208-1213. (Pubitemid 47572359)
80. Manjula N, Gayathri B, Vinaykumar KS, Shankernarayanan NP, Vishwakarma RA, Balakrishnan A. Inhibition of MAP kinases by crude extract and pure compound isolated from Commiphora mukul leads to down regulation of TNF-α, IL-1β and IL-2. Int Immunopharmacol 2006;6:122-132. (Pubitemid 43052809)
81. Singh BB, Mishra LC, Vinjamury SP, Aquilina M, Singh VJ, Shepard N. The effectiveness of Commiphora mukul for osteoarthritis of the knee: An outcomes study. Altern Ther Health Med 2003;9:74-79. (Pubitemid 36576283)
82. Khanna D, Sethi G, Ahn KS, Pandey MK, Kunnumakara AB, Sung B, Aggarwal A, Aggarwal BB. Natural products as a gold mine for arthritis treatment. Curr Opin Pharmacol 2007;7:344-351. (Pubitemid 46731200)
83. Bai L, Wang L, Zhao M, Toki A, Hasegawa T, Ogura H, Kataoka T, Hiroe K, Sakai J, Bai J, Ando M. Bioactive pregnanes from Nerium oleander. J Nat Prod 2007;70:14-18.
84. Giang PM, Jin HZ, Son PT, Lee JH, Hong YS, Lee JJ. ent-Akurane diterpenoids from Croton tonkinensis inhibit LPS-induced NF-κB activation and NO production. J Nat Prod 2003;66:1217-1220.
85. Hong SS, Lee SA, Han XH, Jin HZ, Lee JH, Lee D, Lee JJ, Hong JT, Kim Y, Ro JS, Hwang BY. Akurane diterpenoids from Isodon excisus inhibit LPS-induced NF-κB activation and NO production in macrophage RAW264.7 cells. J Nat Prod 2007;70:632-636. (Pubitemid 46797869)
86. Perez-Garcia F, Martin E, Parella T, Adzet T, Canigueral S. Activity of taraxasteryl acetate on inflammation and heat shock protein synthesis. Phytomedicine 2005;12:278-284. (Pubitemid 40471026)
87. Suksamrarn A, Kumpun S, Kirtikara K, Yingyongnarongkul, Suksamrarn S. Iridoids with antiinflamatory activity from Vitex peduncularis. Planta Med 2002;68:72-73. (Pubitemid 34113595)
88. Yoshikawa K, Inoue M, Mastumoto Y, Sakkakibara C, Miyataka H, Mastumoto H, Arihara S. Lanostane triterpenoids and triterpene glycosides from the fruit body of Fomitopsis pinicola and their inhibitory activity against COX-1 and COX-2. J Nat Prod 2005;68:69-73. (Pubitemid 40175932)
89. Chao K-P, Hua K-F, Hsu H-Y, Su Y-C, Chang S-T. Anti-inflammatory activity of Sugiol, a diterpene isolated from Calocedrus formosana bark. Planta Med 2005;71:300-305.
90. Ma J, Dey M, Yang H, Poulev A, Pouleva R, Dorn R, Lipsky PE, Kennelly EJ, Raskin I. Antiinflammatory and immunosuppressive compounds from Tripterygium wilfordii. Phytochemistry 2007;68:1172-1178. (Pubitemid 46528460)
91. Wu SX, Guo NR. Clinical observation on effect of triptolide tablet in treating patients with psoriasis vulgaris. Chin J Integr Med 2005;11:147-148.
92. Corson TW, Crews CM. Molecular understanding and modern application of traditional medicines: Triumphs and trials. Cell 2007;130:769-774.
93. Sethi G, Ahn KS, Pandey MK, Aggarwal BB. Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-κB-regulated gene products and TAK1-mediated NF-κB activation. Blood 2007;109:2727-2735. (Pubitemid 46482064)
94. Tao X, Younger J, Fan FZ, Wang B, Lipsky PE. Benefit of an extract of Tripterygium wilfordii Hook F in patients with rheumatoid arthritis: A double-blind, placebo-controlled study. Arthritis Rheum 2002;46:1735-1743. (Pubitemid 34774504)
95. Heinrich M. Ethnopharmacology of Mexican asteraceae (compositae). Annu Rev Pharmacol Toxicol 1998;38:539-565.
96. Kwok BHB, Koh B, Ndubuisi MI, Elofsson M, Crews CM. The anti-infammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IκB kinase. Chem Biol 2001;8:759-766. (Pubitemid 32752455)
97. Lindenmeyer MT, Kern C, Sparna T, Donauer J, Wilpert J, Schwager J, Porath D, Kreutz C, Timmer J, Merfort I. Microarray analysis reveals influence of the sesquiterpene lactone parthenolide on gene transcription profiles in human epithelial cells. Life Sci 2007;80:1608-1618. (Pubitemid 46412361)
98. Koo TH, Lee J-H, Park YJ, Hong Y-S, Kim HS, Kim K-W, Lee, JJ. A sesquiterpene lactone, costunolide, from Magnolia grandiflora inhibits NF-κB by targeting IκB phosphorylation. Planta Med 2001;67:103-107.
99. Castro V, Murillo R, Klaas CA, Meunier C, Mora G, Pahl HL, Merfort I. Inhibition of the transcription factor NF-κB by sesquiterpene lactones from Podachaenium eminens. Planta Med 2000;66:591-595. (Pubitemid 30822461)
100. Bocca C, Gabriel L, Bozzo F, Miglietta A. A sesquiterpene lactone, costunolide, interacts with microtubule protein and inhibits the growth of MCF-7 cells. Chem-Biol Interact 2004;147:79-86. (Pubitemid 38076851)
101. Lyß G, Schmidt TJ, Merfort I, Pahl HL. Helenalin, an anti-inflammatory sesquiterpene lactone from Arnica, selectively inhibits transcription factor NF-κB. Biol Chem 1997;378:951-961. (Pubitemid 27438016)
102. Lyß G, Knorre A, Schmidt TJ, Merfort I, Pahl HL. The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-κB by directly targeting p65. J Biol Chem 1998;273:33508-33516. (Pubitemid 29005734)
103. 4 synthase in human blood cells. Biochem Pharmacol 2001;62:903-911.
104. De Marino S, Borbone N, Zollo F, Lanaro A, Di Meglio, Iorizzi M. New sesquiterpene lactones from Laurus nobilis leaves as inhibitors of nitric oxide production. Planta Med 2005;71: 706-710. (Pubitemid 41306188)
105. Siedle B, Gustavsson L, Johansson S, Murillo R, Castro V, Bohlin L, Merfort I. The effect of sesquiterpene lactones on the human neutrophil elastase. Biochem Pharmacol 2003;65:897-903. (Pubitemid 36293705)
106. Rungeler P, Castro V, Mora G, Goren N, Vichnewski W, Pahl HL, Merfort I, Schmidt TJ. Inhibition of transcription factor NF-κB by sesquiterpene lactones: A proposed molecular mechanism of action. Bioorg Med Chem 1999;7:2343-2352. (Pubitemid 30122736)
107. Liu J. Oleanolic acid and ursolic acid: Research perspectives. J Ethnopharmacol 2005;100:92-94. (Pubitemid 41073528)
108. Subbaramaiah K, Michaluart P, Sporn MB, Dannenberg AJ. Ursolic acid inhibits cyclooxygenase-2 transcription in human mammary epithelial cells. Cancer Res 2000;60:2399-2404. (Pubitemid 30262429)
109. Sosa S, Altinier G, Politi M, Braca A, Morelli I, Loggia RD. Extracts and constituents of Lavandula multifida with topical anti-inflammatory activity. Phytomedicine 2005;12:271-277. (Pubitemid 40471025)
110. Baricevic D, Sosa S, Loggia RD, Tubaro A, Simonovska B, Krasna A, Zupancic A. Topical anti-inflammatory activity of Salvia officinalis L. leaves: The relevance of ursolic acid. J Ethnopharmacol 2001;75:125-132. (Pubitemid 32303138)
111. Alvarez ME, Rotelli AE, Pelzer LE, Saad JR, Giordano O. Phytochemical study and anti-inflammatory properties of Lampaya hieronymi Schum. ex Moldenke. IL Farmaco 2000;55: 502-505.
112. Giner-Larza EM, Manez S, Recio MC, Giner RM, Prieto JM, Cerda-Nicolas M, Rios JL. Oleanonic acid, a 3-oxotriterpene from Pistacia, inhibits leukotriene synthesis and has antiinflammatory activity. Eur J Pharmacol 2001;428:137-143. (Pubitemid 32971767)
113. Honda T, Finlay HJ, Gribble GW, Suh N, Sporn MB. New enone derivatives of oleanolic acid and ursolic acid as inhibitors of nitric oxide production in mouse macrophages. Bioorg Med Chem Lett 1997;7:1623-1628. (Pubitemid 27321473)
114. Honda T, Rounds BV, Gribble GW, Suh N, Wang Y, Sporn MB. Design and synthesis of 2-cyano-3,12-dioxooolean-1,9-dien-28-oic acid, a novel and highly active inhibitors of nitric oxide production in mouse macrophages. Bioorg Med Chem Lett 1998;8:2711-2724. (Pubitemid 28496657)
115. Honda T, Rounds BV, Bore L, Jr., Favaloro FG, Gribble GW, Suh N, Wang Y, Sporn MB. Novel synthetic oleanane triterpenoids: A series of highly active inhibitors of nitric oxide production in mouse macrophages. Bioorg Med Chem Lett 1999;9:3429-3434.
116. Honda T, Rounds BV, Bore L, Finlay HJ, Jr., Favaloro FG, Suh N, Wang Y, Sporn MB, Gribble GW. Synthetic oleanane and ursane triterpenoids with modified ring A and C: A series of highly active inhibitors of nitric oxide production in mouse macrophages. J Med Chem 2000;43: 4233-4246. (Pubitemid 30843954)
117. Honda T, Gribble GW, Suh N, Finlay HJ, Rounds BV, Bore L, Jr., Favaloro FG, Wang Y, Sporn MB. Novel synthetic oleanane and ursane triterpenoids with various enone functionalities in ring A as inhibitors of nitric oxide production in mouse macrophages. J Med Chem 2000;43:1866-1877. (Pubitemid 30305019)
118. Honda T, Honda Y, Jr., Favaloro FG, Gribble GW, Suh N, Place AE, Rendi MH, Sporn MB. A novel dicyanotriterpenoid, 2-Cyano-3,12-dioxooleana-1,9(11)- dien-28-onitrile, active at picomolar concentrations for inhibition of nitric oxide production. Bioorg Med Chem Lett 2002;12:1027-1030.
119. http://www.clinicaltrials.gov/ct2/show/NCT00352040?term = CDDO&rank = 1 (accessed on 8-2-2009, last updated on 6-2-2009).
120. Cichewicz RH, Kouzi SA. Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection. Med Res Rev 2004;24:90-114.
121. Sami A, Taru M, Salme K, Jari Y-K. Pharmacological properties of the ubiquitous natural product betulin. Eur J Pharm Sci 2006;29:1-13.
122. Yogeeswari P, Sriram D. Betulinic acid and its derivatives: A review on their biological properties. Curr Med Chem 2005;12:657-666. (Pubitemid 40331058)
123. Bernard P, Scior T, Didier B, Hibert M, Berthon J. Ethnopharmacology and bioinformatic combination for leads discovery: Application to phospholipase A2 inhibitors. Phytochemistry 2001;58:865-874. (Pubitemid 33086211)
124. Takada Y, Aggarwal BB. Betulinic acid suppresses carcinogen-induced NF-κB activation through inhibition of IκBα kinase and p65 phosphorylation: Abrogation of cyclooxygenase-2 and matrix metalloprotease-9. J Immunol 2003;171:3278-3286. (Pubitemid 37093555)
125. Ryu SY, Oak M-H, Yoon S-K, Cho D-I, Yoo G-S, Kim T-S, Kim K-M. Anti-allergic and anti-inflammatory triterpenes from the herb of Prunella vulgaris. Planta Med 2000;66:358-360.
126. Huguet A-I, Recio MC, Manez S, Giner RM, Rios J-L. Effect of triterpenoids on the inflammation induced by protein kinase C activators, neuronally acting irritants and other agents. Eur J Pharmacol 2000;410:69-81.
127. Honda T, Liby KT, Su X, Sundararajan C, Honda Y, Suh N, Risingsong R, Williams CR, Royce DB, Sporn MB, Gribble GW. Design, synthesis, and anti-inflammatory activity both in vitro and in vivo of new betulinic acid analogues having an enone functionality in ring A. Bioorg Med Chem Lett 2006;16:6306-6309. (Pubitemid 44709900)
128. Poeckel D, Werz O. Boswellic Acids: Biological actions and molecular targets. Curr Med Chem 2006;13:3359-3369.
129. Ammon HPT. Boswellic acid in chronic inflammatory diseases. Planta Med 2006;72: 1100-1116.
130. Safayhi H, Mack T, Sabieraj J, Anazodo MI, Subramanian LR, Ammon HPT. Boswellic acids: Novel, specific, nonredox inhibitors of 5-lipoxygenase. J Pharmacol Exp Ther 1992;261: 1143-1146.
131. Sailer ER, Subramanian LR, Rall B, Hoernlein RF, Ammon HPT, Safayhi H. Acetyl-11-keto-beta-boswellic acid (AKBA): Structure requirements for binding and 5-lipoxygenase inhibitory activity. Br J Pharmacol 1996;117:615-618. (Pubitemid 26070238)
132. 2+ and differentially interact with platelet-type 12-lipoxygenase. Mol Pharmacol 2006;70:1071-1078.
133. Siemoneit U, Hofmann B, Kather N, Lamkemeyer T, Madlung J, Franke L, Schneider G, Jauch J, Poeckel D, Werz O. Identification and functional analysis of cyclooxygenase-1 as a molecular target of boswellic acids. Biochem Pharmacol 2008;75:503-513. (Pubitemid 350298477)
134. Singh S, Khajuria A, Taneja SC, Khajuria RK, Singh J, Qazi GN. Boswellic acids and glucosamine show synergistic effect in preclinical anti-inflammatory study in rats. Bioorg Med Chem Lett 2007;17:3706-3711. (Pubitemid 46898805)
135. Kimmatkar N, Thawani V, Hingorani L, Khiyani R. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee - a randomized double blind placebo controlled trial. Phytomedicine 2003;10:3-7. (Pubitemid 36262200)
136. Gupta I, Parihar A, Malhotra P, Gupta S, Ludtke R, Safayhi H, Ammon HPT. Effects of gum resin of Boswellia serrata in patients with chronic colitis. Planta Med 2001;67:391-405.
137. Ende C, Gebhardt R. Inhibition of matrix metalloproteinase-2 and -9 activities by selected flavonoids. Planta Med 2004;70:1006-1008. (Pubitemid 39457814)
138. Ziyan L, Yongmei Z, Nan Z, Ning T, Bohlin L. Evaluation of the anti-inflammatory activity of luteolin in experimental animal models. Planta Med 2007;73:221-226. (Pubitemid 46917473)
139. Jang J, Kim HP, Park H. Structure and anti-inflammatory activity relationships of wogonin derivatives. Arch Pharm Res 2005;28:877-884. (Pubitemid 43086175)
140. 2 production. Planta Med 2002;68:97-100.
141. Laupattarakasem P, Houghton PJ, Hoult JR. Anti-inflammatory isoflavonoids from the stems of Derris scandens. Planta Med 2004;70:496-501. (Pubitemid 38887904)
142. Min B, Oh SR, Lee HK, Takatsu K, Chang IM, Min KR, Kim Y. Sophoricoside analogues as the IL-5 inhibitors from Sophora japonica. Planta Med 1999;65:408-412. (Pubitemid 29299827)
143. Tuchinda P, Reutrakul V, Claeson P, Pongprayoon U, Sematong T, Santisuk T, Taylor WC. Anti-inflammatory cyclohexenyl chalcone derivatives in Boesenbergia pandurata. Phytochemistry 2002;59:169-173. (Pubitemid 34123581)
144. Yun J-M, Kwon H, Hwang J-K. In vitro anti-inflammatory activity of panduratin A isolated from Kaemferia pandurata in RAW264.7 cells. Planta Med 2003;69:1102-1108.
145. Chung M-I, Weng J-R, Wang J-P, Teng C-M, Lin C-N. Antiplatelet and anti-inflammatory constituents and new oxygenated xanthones from Hypericum geminiflorum. Planta Med 2002;68:25-29.
146. 2 in microglia and inhibits neuronal cell death in a middle cerebral artery occlusion-induced focal ischemia mice model. Neurochem Int 2008;52: 878-886.
147. Lee J-H, Zhou HY, Cho SY, Kim YS, Lee YS, Jeong CS. Anti-inflammatory mechanisms of apigenin: Inhibition of cyclooxygenase-2 expression, adhesion of monocytes to human umbilical vein endothelial cells, and expression of cellular adhesion molecules. Arch Pharm Res 2007;30:1318-1327.
148. Nicholas C, Batra S, Vargo MA, Voss OH, Gavrilin MA, Wewers MD, Guttridge DC, Grotewold E, Doseff AI. Apigenin blocks lipopolysaccharide-induced lethality in vivo and pro-inflammatory cytokines expression by inactivating NF-κB through the suppression of p65 phosphorylation. J Immunol 2007;179:7121-7127.
149. Kim HP, Son KH, Chang HW, Kang SS. Anti-inflammatory plant flavonoids and cellular action mechanisms. J Pharmacol Sci 2004;96:229-245. (Pubitemid 40013328)
150. Kim HK, Cheon BS, Kim YH, Kim SY, Kim HP. Effects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their structure-activity relationships. Biochem Pharmacol 1999;58:759-765.
151. Matsuda H, Morikawa T, Ando S, Toguchida I, Yoshikawa M. Structural requirements of flavonoids for nitric oxide production inhibitory activity and mechanism of action. Bioorg Med Chem 2003;11:1995-2000. (Pubitemid 36379016)
152. Matsuda H, Morikawa T, Ueda K, Managi H, Yoshikawa M. Structural requirements of flavonoids for inhibition of antigen-induced degranulation, TNF-α and IL-4 production from RBL-2H3 cells. Bioorg Med Chem 2002;10:3123-3128.
153. Taleb-Contini SH, Kanashiro A, Kabeya LM, Polizello ACM, Lucisano-Valim YM, Oliveira DCR. Immunomodulatory effects of methoxylated flavonoids from two Chromolaena species: Structure-activity relationships. Phytother Res 2006;20:573-575. (Pubitemid 44065139)
154. Chen C-C, Chow M-P, Huang W-C, Lin Y-C, Chang Y-J. Flavonoids inhibit tumor necrosis factor-α-induced upregulation of intercellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cells through activator protein-1 and nuclear factor-κB: Structure-activity relationships. Mol Pharmacol 2004;66:683-693.
155. Lotito SB, Frei B. Dietary flavonoids attenuate tumor necrosis factor α-induced adhesion molecule expression in human aortic endothelial cells. Structure-function relationship and activity after first pass metabolism. J Biol Chem 2006;281:37102-37110. (Pubitemid 46042180)
156. Jung S-H, Cho S-H, Dang TH, Lee J-H, Ju J-H, Kim M-K, Lee S-H, Ryu J-C, Kim Y. Structural requirement of isoflavonones for the inhibitory activity of interleukin-5. Eur J Med Chem 2003;38:537-545. (Pubitemid 36588921)
157. Sadik CD, Sies H, Schewe T. Inhibition of 15-lipoxygenases by flavonoids: Structure-activity relations and mode of action. Biochem Pharmacol 2003;65:773-781. (Pubitemid 36293694)
158. Martinez YV, Ohri RV, Kenyon V, Holman TR, Boza SS. Structure-activity relationship studies of flavonoids as potent inhibitors of human platelet 12-hLO, reticulocyte 15-hLO-1, and prostate epithelial 15-hLO-2. Bioorg Med Chem 2007;15:7408-7425. (Pubitemid 47539136)
159. 2 production in rat peritoneal macrophages: Comparison between subclasses of flavonoids. Phytomedicine 2006;13:310-317.
160. 2 inhibitory biflavonoids. Bioorg Med Chem Lett 2006;16:2373-2375.
161. Agli MD, Bellosta S, Rizzi L, Galli GV, Canavesi M, Rota F, Parente R, Bosisio E, Romeo S. A structure-activity study for the inhibition of metalloproteinase-9 activity and gene expression by analogues of gallocatechin-3-gallate. Cell Mol Life Sci 2005;62:2896-2903. (Pubitemid 41779955)
162. Sartor L, Pezzato E, Aica ID, Caniato R, Biggin S, Garbisa S. Inhibition of matrix-proteases by polyphenols: Chemical insights for anti-inflammatory and anti-invasion drug design. Biochem Pharmacol 2002;64:229-237. (Pubitemid 34775302)
163. Kang BY, Chung SW, Kim SH, Cho D, Kim TS. Involvement of nuclear factor-kappaB in the inhibition of interleukin-12 production from mouse macrophages by baicalein, a flavonoid in Scutellaria baicalensis. Planta Med 2003;69:687-691. (Pubitemid 37215014)
164. Deschamps JD, Kenyon VA, Holman TR. Baicalein is a potent in vitro inhibitor against both reticulocyte 15-human and platelet 12-human lipoxygenases. Bioorg Med Chem 2006;14:4295-4301.
165. Huang W-H, Lee A-R, Chien P-Y, Chou T-Z. Synthesis of baicalein derivatives as potential antiaggregatory and anti-inflammatory agents. J Pharm Pharmacol 2005;57:219-225. (Pubitemid 40129090)
166. Cho H, Yun C-W, Park W-K, Kong J-Y, Kim KS, Park Y, Lee S, Kim B-K. Modulation of the activity of pro-inflammatory enzymes, COX-2 and iNOS, by chrysin derivatives. Pharmacol Res 2004;49:37-43. (Pubitemid 37324901)
167. Cho JY, Baik KU, Yoo ES, Yoshikawa K, Park MH. In vitro anti-inflammatory effects of neolignan woorenosides from the rhizomes of Coptis japonica. J Nat Prod 2000;63: 1205-1209.
168. Cho JY, Kim AR, Park MH. Lignans from the rhizomes of Coptis japonica differentially act as anti-inflammatory principles. Planta Med 2001;67:312-316.
169. Saleem M, Kim HJ, Ali MS, Lee YS. An update on bioactive plant lignans. Nat Prod Rep 2005;22:696-716.
170. Prieto JM, Giner RM, Recio MC, Schinella G, Manez S, Rios JL. Diphyllin acetylapioside, a 5-lipoxygenase inhibitor from Halophyllum hispanicum. Planta Med 2002;68:359-360. (Pubitemid 34494050)
171. Hwang BY, Lee J-H, Nam JB, Hong Y-S, Lee JJ. Lignans from Saururus chinensis inhibiting the transcription factor NF-kB. Phytochemistry 2003;64:765-771.
172. Zschocke S, van Staden J, Paulus K, Bauer R, Horn MM, Munro OQ, Brown NJ, Drewes SE. Stereostructure and anti-inflammatory activity of three diastereomers of ocobullenone from Ocotea bullata. Phytochemistry 2000;54:591-595. (Pubitemid 30625834)
173. Weng J-R, Tsao L-T, Wang J-P, Wu R-R, Lin C-N. Anti-inflammatory phloroglucinols and terpenoids from Garcinia subelliptica. J Nat Prod 2004;67:1796-1799.
174. Appendino G, Ottino M, Marquez N, Bianchi F, Giana A, Ballero M, Sterner O, Fiebich BL, Munoz E. Arzanol, an anti-inflammatory and anti-HIV phloroglucinol α-pyrone from Helichrysum italicum ssp. microphyllum. J Nat Prod 2007;70:608-612. (Pubitemid 46797865)
175. Kang BK, Chung SW, Kim TS. Inhibition of interleukin-12 production in lipopolysaccharide-activated mouse macrophages by hypericin, an active component of Hypericum perforatum. Planta Med 2001;67:364-366.
176. Wube AA, Bucar F, Asres K, Gibbons S, Adams M, Streit B, Bodensieck A, Bauer R. Knipholone, a selective inhibitor of leukotriene metabolism. Phytomedicine 2006;13:452-456. (Pubitemid 43728730)
177. Abourashed EA, Muhammad I, Resch M, Bauer R, El-Feraly FS, Hufford CD. Inhibitory effects of maesanin and analogues on arachidonic acid metabolizing enzymes. Planta Med 2001;67:360-361. (Pubitemid 32588575)
178. 2 biosynthesis. Planta Med 2005;71:739-742.
179. Aggarwal BB, Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 2006;71:1397-1421.
180. Folmer F, Jaspars M, Dicato M, Diederich M. Marine natural products as targeted modulators of the transcription factor NF-κB. Biochem Pharmacol 2008;75:603-617.
181. Huang Q, Shen H-M, Ong C-N. Inhibitory effect of emodin on tumor invasion through suppression of activator protein-1 and nuclear factor-κB. Biochem Pharmacol 2004;68:361-371. (Pubitemid 38757705)
182. Matsui T, Ito C, Itoigawa M, Okada T, Furukawa H. Anti-inflammatory activity of phenylpropanoids and plastoquinoids from Illicium species in RBL-2H3 cells. Planta Med 2007;73:662-665. (Pubitemid 47066159)
183. Lee JY, Woo E-R, Kang KW. Inhibition of lipopolysaccharide-inducible nitric oxide synthase expression by acteoside through blocking of AP-1 activation. J Ethnopharmacol 2005;97: 561-566. (Pubitemid 40312335)
184. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: The in vivo evidence. Nat Rev Drug Discov 2006;5:493-506.
185. Bi XL, Yang JY, Dong YX, Wang JM, Cui YH, Ikeshima T, Zhao YQ, Wu CF. Resveratrol inhibits nitric oxide and TNF-α production by lipopolysaccharide-activated microglia. Int Immunopharmacol 2005;5:185-193. (Pubitemid 39626704)
186. Csaki C, Keshishzadeh N, Fischer K, Shakibaei M. Regulation of inflammation signaling by resveratrol in human chondrocytes in vitro. Biochem Pharmacol 2008;75:677-687.
187. Kundu JK, Shin YK, Surh Y-J. Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-κB and AP-1 as prime targets. Biochem Pharmacol 2006;72:1506-1515.
188. Wu CC, Wu CI, Wang WY, Wu YC. Low concentrations of resveratrol potentiate the antiplatelet effect of prostaglandins. Planta Med 2007;73:439-443.
189. Elmali N, Baysai O, Harma A, Esenkaya I, Mizrak B. Effects of resveratrol in inflammatory arthritis. Inflammation 2007;1-2:1-6.
190. Elmali N, Esenkaya I, Harma A, Ertem K, Turkoz Y, Mizrak B. Effect of resveratrol in experimental osteoarthritis in rabbits. Inflamm Res 2005;54:158-162. (Pubitemid 41178921)
191. Chung K-O, Kim B-Y, Lee M-H, Kim Y-R, Chung H-Y, Park J-H, Moon J-O. In-vitro and in vivo anti-inflammatory effect of oyresveratrol from Morus alba L. J Pharm Pharmacol 2003;55:1695-1700.
192. Patel B, Patel S, Hoffman R. Inhibition of cyclooxygenase-2 expression in mouse macrophages by 4-(3-methyl-but-1-enyl)-3,5,3′,4′- tetrahydroxystilbene, a resveratrol derivative from peanuts. Phytother Res 2005;19:552-555.
193. Chung EY, Kim BH, Lee MK, Yun Y-P, Lee SH, Min KR, Kim Y. Anti-inflammatory effect of the oligomeric stilbene α-Viniferin and its mode of action through inhibition of cyclooxygenase-2 and inducible nitric oxide synthase. Planta Med 2003;69:710-714. (Pubitemid 37215019)
194. Lee JY, Kim J-H, Kang SS, Bae CS, Choi SH. The effects of α-Viniferin on adjuvant-induced arthritis in rats. Am J Chin Med 2004;32:521-530. (Pubitemid 39302670)
195. Murias M, Handler N, Erker T, Pleban K, Ecker G, Saiko P, Szekeresb T, Jager W. Resveratrol analogues as selective cyclooxygenase-2 inhibitors: Synthesis and structure-activity relationship. Bioorg Med Chem 2004;12:5571-5578. (Pubitemid 39304056)
196. Handler N, Brunhofer G, Studenik C, Leisser K, Jager W, Parth S, Erker T. "Bridged" stilbene derivatives as selective cyclooxygenase-1 inhibitors. Bioorg Med Chem 2007:15:6109-6118.
197. Cho D-I, Koo N-Y, Chung WJ, Kim T-S, Ryu SY, Im SY, Kim K-M. Effects of resveratrol-related hydroxystilbenes on the nitric oxide production in macrophage cells: Structural requirements and mechanism of action. Life Sci 2002;71:2071-2082.
198. Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as "Curecumin": From kitchen to clinic. Biochem Pharmacol 2008;75:787-809.
199. Singh S. From exotic spice to modern drug? Cell 2007;130:765-768.
200. Maheshwari RK, Singh AK, Gaddipati J, Srimal RC. Multiple biological activities of curcumin: A short review. Life Sci 2006;78:2081-2087.
201. Chattopadhyay I, Biswas K, Bandyopadhyay U, Banerjee RK. Turmeric and curcumin: Biological actions and medicinal applications. Curr Sci 2004;87:44-53. (Pubitemid 39403908)
202. Natrajan C, Bright JJ. Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through janus kinase-ATAT pathway in T lympbocytess. J Immunol 2002;169:6503-6513.
203. Liacini A, Sylvester J, Qing LW, Huang W, Dehnade F, Ahmad M, Zafarullah M. Induction of matrix metalloproteinase-13 gene expression by TNF-alpha is mediated by MAP kinases, AP-1, and NF-B transcription factors in articular chondrocytes. Exp Cell Res 2003;25:208-217.
204. Banerjee M, Tripathi LM, Srivastava VM, Puri A, Shukla R. Modulation of inflammatory mediators by ibuprofen and curcumin treatment during chronic inflmammation in rat. Immunopharmacol Immunotoxicol 2003;25:213-224. (Pubitemid 36597418)
205. Durgaprasad S, Pai CG, Vasanthkumar, Alvres JF, Namitha S. A pilot study of the antioxidant effect of curcumin in tropical pancreatitis. Indian J Med Res 2005;122:315-318. (Pubitemid 43091515)
206. Lee S-L, Huang W-J, Lin WW, Lee S-S, Chen C-H. Preparation and anti-inflammatory activities of diarylheptanoid and diarylheptylamine analogues. Bioorg Med Chem 2005;13:6175-6181. (Pubitemid 41400139)
207. Lee M-W, Kim N-Y, Park M-S, Ahn K-H, Toh S-H, Hahn D-R, Kim Y-C, Chung H-T. Diarylheptanoids with in vitro inducible nitric oxide synthesis inhibitory activity from Alnus hirsuta. Planta Med 2000;66:551-553.
208. Gafner S, Lee S-K, Cuendet M, Barthelemy S, Vergnes L, Labidalle S, Mehta RG, Boone CW, Pezzuto JM. Biologic evaluation of curcumin and structural derivatives in cancer chemoprevention model systems. Phytochemistry 2004;65:2849-2859. (Pubitemid 40292116)
209. Handler N, Jaeger W, Puschacher H, Leisser K, Erker T. Synthesis of novel curcumin analogues and their evaluation as selective cyclooxygenase-1 (COX-1) inhibitors. Chem Pharm Bull 2007;55:64-71. (Pubitemid 46067584)
210. Liang G, Li X, Chen L, Yang S, Wu X, Studer E, Gurley E, Hylemon PB, Ye F, Li Y, Zhou H. Synthesis and anti-inflammatory activities of mono-carbonyl analogues of curcumin. Bioorg Med Chem Lett 2008;18:1525-1529. (Pubitemid 351226515)
211. Pearce An, Chia EW, Berridge MW, Clark GR, Harper JL, Larsen L, Maas EW, Page MJ, Perry NB, Webb VL, Copp BR. Anti-inflammatory thiazine alkaloids isolated from the New Zealand ascidian Alpidium sp.: Inhibitors of the neutrophil respiratory burst in a model of gouty arthritis. J Nat Prod 2007;70:936-940. (Pubitemid 47056106)
212. Harinantenaina L, Asakawa Y. Chemical constituents of Malagasy liverworts. 6. A myltaylane caffeate with nitric oxide inhibitory activity from Bazzania nitida. J Nat Prod 2007;70:856-858.
213. Nakao Y, Fusetani N. Enzyme inhibitors from marine invertebrates. J Nat Prod 2007;70:689-710.
214. Shen Y-C, Chen S-Y, Kuo Y-H, Huang T-L, Chiang MY, Khalil AT. Chemical transformation and biological activities of ambrein, a major product of ambergris from Physeter macrocephalus (Sperm Whale). J Nat Prod 2007;70:147-153.
215. Fujita M, Nakao Y, Matsunaga S, Nishikawa T, Fusetani N. Sodium 1-(12-hydroxy)octadecanyl sulfate, an MMP-2 inhibitor, isolated from tunicate of the family polyclinidae. J Nat Prod 2002;65:1936-1938.
216. 2 with manoalide. J Med Chem 1993;36:1866-1879.
217. Newman DJ, Cragg GM. Advanced preclinical and clinical trials of natural products and related compounds from marine sources. Curr Med Chem 2004;11:1693-1713. (Pubitemid 38821339)
218. De Rosa M, Giordano S, Scettri A, Sodano G, Soriente A, Pastor PG, Alcaraz MJ, Paya M. Synthesis and comparison of the antiinflammatory activity of manoalide and cacospongionolide B analogues. J Med Chem 1998;41:3232-3238. (Pubitemid 28376528)
219. 2 and other leukocyte functions. J Nat Prod 2001;64:612-615.
220. 2 inactivation. Chembiochem 2007;8:1585-1591.
221. Xie Y, Liu L, Huang X, Guo YW, Lou L. Scalaradial inhibition of epidermal growth factor receptor-mediated Akt phosphorylation is independent of secretory phospholipase A2. J Pharmacol Exp Ther 2005;314:1210-1217. (Pubitemid 41205986)
222. Xie Y, Yu Z, Liu L, Guo Y, Lou L. Biphasic regulation of extracellular signal-regulated kinases by scalaradial, a secretory phospholipase A2 inhibitor. Cancer Biol Ther 2006;5:988-992. (Pubitemid 44776520)
223. Hussein G, Sankawa U, Gato H, Matsumoto K, Watanabe H. Astaxanthin, a carotenoid with potential in human health and nutrition. J Nat Prod 2006;69:443-449.
224. Terracciano S, Aquino M, Rodriquez M, Monti MC, Casapullo A, Riccio R, Gomez-Paloma L. Chemistry and biology of anti-inflammatory marine natural products: Molecules interfering with cyclooxygenase, NF-κB and other unidentified targets. Cur Med Chem 2006;13:1947-1969.
225. Mayer AMS, Rodriguez AD, Berlinck RGS, Hamann MT. Marine pharmacology in 2003-4: Marine compounds with anthelmintic, antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action. Comp Biochem Physiol C 2007;145:553-581. (Pubitemid 46660746)
226. Lucas R, Giannini C, D'auria MV, Paya M. Modulatory effect of bolinaquinone, a marine sesquiterpenoid, on acute and chronic inflammatory processes. J Pharmacol Exp Ther 2003;304:1172-1180. (Pubitemid 36254430)
227. Mayer AMS, Hamann MT. Marine pharmacology in 2001-2002: Marine compounds with anthelmintic, antibacterial, anticoagulant, antidiabetic, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action. Comp Biochem Physiol C 2005;140:265-286.
228. Potterat O, Hamburger M. Drug discovery and development with plant-derived compounds. In: Petersen F, Amstutz R, editors. Progress in drug research. Vol.65. Switzerland: Birkhauser Verlag; 2008. pp 46-118.
229. Boonphong S, Puangsombat P, Baramee A, Mahidol C, Ruchirawat S, Kittakoop P. Bioactive compounds from Bauhinia purpurea possessing antimalarial, antimycobacterial, antifungal, anti-inflammatory, and cytotoxic activities. J Nat Prod 2007;70:795-801. (Pubitemid 46953602)
230. Chen J-J, Lin W-J, Liao C-H, Shieh P-C. Anti-inflammatory benzenoids from Antrodia camphorata. J Nat Prod 2007;70:989-992.
231. Zhang X, Xu J-K, Wang J, Wang N-L, Kurihara H, Kitanaka S, Yao X-S. Bioactive bibenzyl derivatives and fluorenones from Dendrobium nobile. J Nat Prod 2007;70:24-28. (Pubitemid 46270208)
232. Jeenapongsa R, Yoovathaworn K, Sriwatanakul KM, Pongprayoon U, Kampon SK. Anti-inflammatory activity of (E)-1-(3,4-dimethoxyphenyl) butadiene from Zingiber cassumunar Roxb. J Ethnopharmacol 2003;87:143-148.
233. Xu M-Z, Lee WS, Han J-M, Oh H-W, Park D-S, Tian G-R, Jeong T-S, Park H-Y. Antioxidant and anti-inflammatory activities of N-acetyldopamine dimers from Periostracum cicadae. Bioorg Med Chem 2006;14:7826-7834.
234. Rios MY, Aguilar-Guadarrama B. Nitrogen-containg phorbol esters from Croton ciliatoglandulifer and their effects on cyclooxygenases-1 and -2. J Nat Prod 2006;69:887-890.
235. 2 synthesis in RAW264.7 macrophages through the inhibition of iNOS and COX-2 gene expression. Life Sci 2004;75:675-684.
236. Duan H, Zhang Y, Xu J, Qiao J, Suo Z, Hu G, Mu X. Effect of anemonin on NO, ET-1 and ICAM-1 production in rat intestinal microvascular endothelial cells. J Ethnopharmacol 2006;104:362-366. (Pubitemid 43356649)
237. Son HJ, Lee HJ, Yun-Choi HS, Ryu J-H. Inhibitors of nitric oxide synthesis and TNF-α expression from Magnolia obovata in activated macrophages. Planta Med 2000;66:469-471.
238. Lee J, Jung E, Park J, Jung K, Lee S, Hong S, Park J, Park E, Kim J, Park S, Park D. Anti-inflammatory effects of magnolol and honokiol are mediated through inhibition of the downstream pathway of MEKK-1 in NF-κB activation signaling. Planta Med 2005;71:338-343. (Pubitemid 40676458)
239. Tse AK-W, Wan C-K, Shen X-L, Yang M, Fong W-F. Honokiol inhibits TNF-α-stimulated NF-κB activation and NF-κB-regulated gene expression through suppression of IKK activation. Biochem Pharmacol 2005;70:1443-1457. (Pubitemid 41483455)
240. Costa B, Trovato AE, Comelli F, Giagnoni G, Colleoni M. The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain. European J Pharmacol 2007;556:75-83. (Pubitemid 46074009)
241. Darmani NA, Izzo AA, Degenhardt B, Valenti M, Scaglione G, Capasso R, Sorrentini I, Marzo VD. Involvement of the cannabimimetic compound, N-palmitoyl-ethanolamine, in inflammatory and neuropathic conditions: Review of the available pre-clinical data, and first human studies. Neuropharmacol 2005;48:1154-1163. (Pubitemid 40725988)